IMMX logo

Immix Biopharma (IMMX) Company Overview

Profile

Full Name:

Immix Biopharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 16, 2021

Indexes:

Not included

Description:

Immix Biopharma (IMMX) is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. They aim to improve patient outcomes through advanced treatments, including immune-based therapies and targeted drug delivery systems, leveraging cutting-edge research and technology.

Events Calendar

Earnings

Next earnings date:

Feb 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 6, 25 HC Wainwright & Co.
Buy
Oct 3, 24 HC Wainwright & Co.
Buy
Aug 19, 24 HC Wainwright & Co.
Buy
Jul 26, 24 HC Wainwright & Co.
Buy
Jul 9, 24 HC Wainwright & Co.
Buy
Jul 1, 24 HC Wainwright & Co.
Buy
Aug 14, 23 Roth MKM
Buy
Feb 22, 23 Roth MKM
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Immix Biopharma?
  • Does Immix Biopharma pay dividends?
  • What sector is Immix Biopharma in?
  • What industry is Immix Biopharma in?
  • What country is Immix Biopharma based in?
  • When did Immix Biopharma go public?
  • Is Immix Biopharma in the S&P 500?
  • Is Immix Biopharma in the NASDAQ 100?
  • Is Immix Biopharma in the Dow Jones?
  • When was Immix Biopharma's last earnings report?
  • When does Immix Biopharma report earnings?
  • Should I buy Immix Biopharma stock now?

What is the ticker symbol for Immix Biopharma?

The ticker symbol for Immix Biopharma is NASDAQ:IMMX

Does Immix Biopharma pay dividends?

No, Immix Biopharma does not pay dividends

What sector is Immix Biopharma in?

Immix Biopharma is in the Healthcare sector

What industry is Immix Biopharma in?

Immix Biopharma is in the Biotechnology industry

What country is Immix Biopharma based in?

Immix Biopharma is headquartered in United States

When did Immix Biopharma go public?

Immix Biopharma's initial public offering (IPO) was on December 16, 2021

Is Immix Biopharma in the S&P 500?

No, Immix Biopharma is not included in the S&P 500 index

Is Immix Biopharma in the NASDAQ 100?

No, Immix Biopharma is not included in the NASDAQ 100 index

Is Immix Biopharma in the Dow Jones?

No, Immix Biopharma is not included in the Dow Jones index

When was Immix Biopharma's last earnings report?

Immix Biopharma's most recent earnings report was on Nov 12, 2024

When does Immix Biopharma report earnings?

The next expected earnings date for Immix Biopharma is Feb 14, 2025

Should I buy Immix Biopharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions